Skip Navigation
  Print Page

Muscular Dystrophy: NICHD Research Information

Skip sharing on social media links
Share this:

NICHD research on muscular dystrophy (MD) encompasses a wide variety of topics, including basic, translational, and clinical studies. The NICHD and other NIH institutes are working to develop new therapies for Duchenne and Becker MD. NICHD-funded studies also aim to identify the underlying molecular and cellular pathology of facioscapulohumeral (pronounced fas-see-oh-skap-you-low-HEW-mur-l) muscular dystrophy (FSHD). Scientists are currently establishing a biomarker database for FSHD research, which collects information gathered from muscle tissue and cell repositories. Through the National Center for Medical Rehabilitation Research, NICHD research encompasses the impacts of musculoskeletal disorders on motor and sensory functions, bone loss, obesity, muscle atrophy, pressure ulcers, bladder and bowel disorders, and pain, in addition to psychological and psychosocial conditions and limitations in mobility.

Last Updated Date: 11/30/2012
Last Reviewed Date: 12/06/2013
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology